Evaluating Hunger Manipulation During Feeding Intervention

Status Completed

Clinical Trial Summary

The primary objective of this study is to determine to what extent hunger provocation, via rapid weaning from enteral feedings, is acceptable and feasible and to evaluate the effect of this intervention when used in an intensive multidisciplinary feeding intervention (IMFI) model of treatment (standard care), for individuals with Avoidant Food Intake Disorder (ARFID) who are dependent on enteral feedings to meet their daily caloric needs.

Clinical Trial Description

The recognized standard of care for children dependent on feeding tubes is intensive multidisciplinary feeding intervention (IMFI) involving a professional team that includes psychologists, physicians, nurse practitioners, registered dietitian nutritionists, and speech-language pathologists/occupational therapists working together in inpatient or day hospital settings. A meta-analysis of 11 studies involving intensive, multidisciplinary intervention reported that 71% (95% CI, 54%-83%) of 454 patients successfully weaned from feeding tube dependence at discharge from inpatient or intensive day treatment programs. Treatment gains were maintained following discharge, with 80% (95% CI, 66%-89%) of 414 patients successfully weaned from tube feedings at last follow-up. The most common treatment approaches documented by the meta-analysis involved behavioral intervention and tube weaning (hunger manipulation - evoking a state of hunger to encourage oral consumption by rapidly weaning from the tube). The review highlighted the lack of consensus among clinicians and researchers regarding the criteria for, rate of, and timing of weaning from enteral feedings. As a result, the authors concluded that the relative contribution of aggressive tube weaning as a standalone or adjunctive therapy to behavioral intervention remains uncertain. The primary objective of this study is to determine to what extent hunger provocation, via rapid weaning from enteral feedings, is acceptable and feasible and to evaluate the effect of this intervention when used as an adjunct to our standard model of behavioral intervention within the study team's IMFI program, for individuals with Avoidant Food Intake Disorder (ARFID) who are dependent on enteral feedings to meet their daily caloric needs. ;

Study Design

Related Conditions & MeSH terms

Avoidant/Restrictive Food Intake Disorder
Feeding and Eating Disorders
Feeding Disorders

Clinical Trial Details

NCT number	NCT05053438
Study type	Interventional
Source	Emory University
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2021
Completion date	October 18, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03247946` - The Influence of Upright Feeding Position on Pulmonary and Ear Morbidity	N/A
Completed	`NCT03202576` - Nasogastric Tube Securement Comparison Study	N/A
Recruiting	`NCT05587127` - Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia	N/A
Completed	`NCT03211468` - Intervention Program to Improve Body Image and Self-Esteem Among Female Athletes.	N/A
Completed	`NCT03759444` - Perception of Time by Individuals With Eating Disorders
Recruiting	`NCT06256380` - Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder	N/A
Active, not recruiting	`NCT03808467` - Cognitive Training for Patients With Eating Disorders	N/A
Recruiting	`NCT03684239` - The Effect of G-CBT on the Patients With AN	N/A
Completed	`NCT04431284` - Impact of COVID-19 Lockdown on Obesity and Eating Behaviors
Active, not recruiting	`NCT03987984` - Reliability and Validity of the Turkish Version of the Sensory Eating Problems Scale
Completed	`NCT03455088` - The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled Study	N/A
Not yet recruiting	`NCT06057415` - Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System	N/A
Not yet recruiting	`NCT05873127` - Web-based Guided Self-help CBT-E vs Online G-CBT-E for Binge Eating Behavior	N/A
Completed	`NCT03490786` - A Dose Escalating Study to Assess the Safety and Tolerability of GT-001	Phase 1
Completed	`NCT03375853` - Computerized Response Training Obesity Treatment	N/A
Recruiting	`NCT05186441` - The Effect of iTBS on the Inhibition Control Function of BN	N/A
Active, not recruiting	`NCT03968705` - Longstanding Eating Disorders and Personality Disorders
Recruiting	`NCT05038033` - Addressing Anxiety and Stress for Healthier Eating in Teens	N/A
Not yet recruiting	`NCT06266507` - Examining the Effect of Occupational Therapy-Based Parent Coaching on Feeding Problems in Children With a Preterm Birth	N/A
Terminated	`NCT04837989` - Effectiveness of the Diabetes Body Project Among Females With Type 1 Diabetes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.